Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stroke

Free Subscription Articles published in Lancet Neurol Retrieve available abstracts of 163 articles: HTML format

Single Articles

July 2021
1. BANDINI F, Vestito L, Filippi L
   Prehospital scales in acute ischaemic stroke management.
   Lancet Neurol. 2021;20:504.
   PubMed    
   
   
   
2. DUVEKOT MHC, Venema E, Kerkhoff H, Dippel DWJ, et al
   Prehospital scales in acute ischaemic stroke management - Authors' reply.
   Lancet Neurol. 2021;20:504-505.
   PubMed    
   
   
   June 2021
3. LI L, Poon MTC, Samarasekera NE, Perry LA, et al
   Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
   Lancet Neurol. 2021;20:437-447.
   PubMed     Abstract available
   
   
   
4. HAEUSLER KG, Kirchhof P, Kunze C, Tutuncu S, et al
   Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.
   Lancet Neurol. 2021;20:426-436.
   PubMed     Abstract available
   
   
   
5. CHENG X, Dong Q
   Towards individualised secondary prevention after intracerebral haemorrhage.
   Lancet Neurol. 2021;20:411-413.
   PubMed    
   
   
   
6. WASSERLAUF J, Volgman AS
   Monitoring for atrial fibrillation after stroke.
   Lancet Neurol. 2021;20:410-411.
   PubMed    
   
   
   May 2021
7. JORDAN LC, DeBaun MR, Donahue MJ
   Advances in neuroimaging to improve care in sickle cell disease.
   Lancet Neurol. 2021;20:398-408.
   PubMed     Abstract available
   
   
   
8. HACHINSKI V, Avan A, Gilliland J, Oveisgharan S, et al
   A new definition of brain health.
   Lancet Neurol. 2021;20:335-336.
   PubMed    
   
   
   April 2021
9. WEAVER NA, Kuijf HJ, Aben HP, Abrigo J, et al
   Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.
   Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00060.
   PubMed     Abstract available
   
   
   
10. PANTONI L, Salvadori E
    Location of infarcts and post-stroke cognitive impairment.
    Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00107.
    PubMed    
    
    
    
11. BEST JG, Ambler G, Wilson D, Lee KJ, et al
    Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from
    Lancet Neurol. 2021;20:294-303.
    PubMed     Abstract available
    
    
    
12. GREENBERG SM
    Cerebral microbleeds and prediction of intracranial haemorrhage.
    Lancet Neurol. 2021;20:252-254.
    PubMed    
    
    
    
13. ZIAI WC, Al-Kawaz M
    Blood pressure management after endovascular therapy.
    Lancet Neurol. 2021;20:248-249.
    PubMed    
    
    
    
14. LAUMANN TO, Ortega M, Hoyt CR, Seider NA, et al
    Brain network reorganisation in an adolescent after bilateral perinatal strokes.
    Lancet Neurol. 2021;20:255-256.
    PubMed    
    
    
    March 2021
15. SCHMIDT R, Hofer E
    Identifying novel genetic risk loci for lacunar stroke.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00099.
    PubMed    
    
    
    
16. TRAYLOR M, Persyn E, Tomppo L, Klasson S, et al
    Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studies.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00031.
    PubMed     Abstract available
    
    
    
17. ENGELTER ST, Traenka C, Gensicke H, Schaedelin SA, et al
    Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
    Lancet Neurol. 2021 Mar 22. pii: S1474-4422(21)00044.
    PubMed     Abstract available
    
    
    
18. HOWARD DPJ, Gaziano L, Rothwell PM
    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.
    Lancet Neurol. 2021;20:193-202.
    PubMed     Abstract available
    
    
    
19. VAN DIJCK JTJM, Kompanje EJO, Nederkoorn PJ, Peul WC, et al
    Advanced consent for acute stroke trials - Authors' reply.
    Lancet Neurol. 2021;20:170-171.
    PubMed    
    
    
    
20. SHAMY M, Dewar B, Niznick N, Nicholls S, et al
    Advanced consent for acute stroke trials.
    Lancet Neurol. 2021;20:170.
    PubMed    
    
    
    
21. SPENCE JD
    Treatment of asymptomatic carotid stenosis.
    Lancet Neurol. 2021;20:163-165.
    PubMed    
    
    
    February 2021
22. MAZIGHI M, Richard S, Lapergue B, Sibon I, et al
    Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2021 Feb 26. pii: S1474-4422(20)30483.
    PubMed     Abstract available
    
    
    January 2021
23. DUVEKOT MHC, Venema E, Rozeman AD, Moudrous W, et al
    Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30439.
    PubMed     Abstract available
    
    
    
24. GOYAL M, Marko M
    Optimising prehospital stroke triage in a changing landscape.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30488.
    PubMed    
    
    
    
25. TSIVGOULIS G, Katsanos AH
    Important advances in stroke research in 2020.
    Lancet Neurol. 2021;20:2-3.
    PubMed    
    
    
    December 2020
26. WU S, Anderson CS
    Healthy eating for secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30450.
    PubMed    
    
    
    
27. ENGLISH C, MacDonald-Wicks L, Patterson A, Attia J, et al
    The role of diet in secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30433.
    PubMed     Abstract available
    
    
    
28. SILBERGLEIT R, Dickert NW
    Context and principles must drive alternatives to consent in emergency research.
    Lancet Neurol. 2020;19:968-969.
    PubMed    
    
    
    November 2020
29. THE LANCET NEUROLOGY
    A unified European action plan on stroke.
    Lancet Neurol. 2020 Nov 6. pii: S1474-4422(20)30409.
    PubMed    
    
    
    October 2020
30. MERETOJA A, Yassi N, Wu TY, Churilov L, et al
    Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2020 Oct 28. pii: S1474-4422(20)30369.
    PubMed     Abstract available
    
    
    
31. KOMPANJE EJO, van Dijck JTJM, Chalos V, van den Berg SA, et al
    Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke.
    Lancet Neurol. 2020 Oct 21. pii: S1474-4422(20)30276.
    PubMed     Abstract available
    
    
    September 2020
32. FIFI JT, Mocco J
    COVID-19 related stroke in young individuals.
    Lancet Neurol. 2020;19:713-715.
    PubMed    
    
    
    August 2020
33. 
    Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:661-669.
    PubMed     Abstract available
    
    
    
34. 
    Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:651-660.
    PubMed     Abstract available
    
    
    
35. KWAKKEL G, Meskers C, Ward NS
    Time for the next stage of stroke recovery trials.
    Lancet Neurol. 2020;19:636-637.
    PubMed    
    
    
    July 2020
36. FASSBENDER K, Walter S, Grunwald IQ, Merzou F, et al
    Prehospital stroke management in the thrombectomy era.
    Lancet Neurol. 2020;19:601-610.
    PubMed     Abstract available
    
    
    
37. MOHR JP, Overbey JR, Hartmann A, Kummer RV, et al
    Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Lancet Neurol. 2020;19:573-581.
    PubMed     Abstract available
    
    
    May 2020
38. HURFORD R, Wolters FJ, Li L, Lau KK, et al
    Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.
    Lancet Neurol. 2020;19:413-421.
    PubMed     Abstract available
    
    
    
39. HERMANN DM, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Refining endpoints for stroke recovery trials.
    Lancet Neurol. 2020;19:381-382.
    PubMed    
    
    
    
40. UCHIYAMA S
    Intensive medical management of intracranial arterial stenosis.
    Lancet Neurol. 2020;19:371-373.
    PubMed    
    
    
    
41. THE LANCET NEUROLOGY
    The fight against stroke must go on.
    Lancet Neurol. 2020;19:369.
    PubMed    
    
    
    
42. MORGAN J
    Werner Hacke: a new era for stroke patients.
    Lancet Neurol. 2020;19:387.
    PubMed    
    
    
    March 2020
43. CHABRIAT H, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2020;19:226-233.
    PubMed     Abstract available
    
    
    
44. CRAMER SC
    Issues important to the design of stroke recovery trials.
    Lancet Neurol. 2020;19:197-198.
    PubMed    
    
    
    
45. GOYAL M, Ospel J
    Challenges to stroke care 5 years after endovascular therapy became the standard.
    Lancet Neurol. 2020;19:210-211.
    PubMed    
    
    
    January 2020
46. STINEAR CM, Lang CE, Zeiler S, Byblow WD, et al
    Advances and challenges in stroke rehabilitation.
    Lancet Neurol. 2020 Jan 28. pii: S1474-4422(19)30415.
    PubMed     Abstract available
    
    
    
47. WU S, Cheng Y, Wu B, Liu M, et al
    Stroke research in 2019: towards optimising treatment and prevention.
    Lancet Neurol. 2020;19:2-3.
    PubMed    
    
    
    December 2019
48. SCHONEWILLE WJ
    BEST evidence on mechanical thrombectomy for patients with vertebrobasilar occlusion.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30477.
    PubMed    
    
    
    
49. LIU X, Dai Q, Ye R, Zi W, et al
    Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30395.
    PubMed     Abstract available
    
    
    November 2019
50. AHMADI M, Laumeier I, Ihl T, Steinicke M, et al
    A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30369.
    PubMed     Abstract available
    
    
    
51. LI L
    Support programme for secondary prevention of stroke: inspiration to continue?
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30410.
    PubMed    
    
    
    
52. BAYONA-ORTIZ H, Useche JN, Yanez N, Velasco SC, et al
    Availability of stroke units in Colombia.
    Lancet Neurol. 2019;18:988.
    PubMed    
    
    
    October 2019
53. THE LANCET NEUROLOGY
    Global prevention of stroke: focus on the individual?
    Lancet Neurol. 2019;18:903.
    PubMed    
    
    
    September 2019
54. MOULLAALI TJ, Wang X, Martin RH, Shipes VB, et al
    Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
    Lancet Neurol. 2019;18:857-864.
    PubMed     Abstract available
    
    
    
55. FLOEL A
    Computerised speech and language therapy in post-stroke aphasia.
    Lancet Neurol. 2019;18:806-807.
    PubMed    
    
    
    
56. PALMER R, Dimairo M, Cooper C, Enderby P, et al
    Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Lancet Neurol. 2019;18:821-833.
    PubMed     Abstract available
    
    
    July 2019
57. SHI K, Tian DC, Li ZG, Ducruet AF, et al
    Global brain inflammation in stroke.
    Lancet Neurol. 2019 Jul 8. pii: S1474-4422(19)30078.
    PubMed     Abstract available
    
    
    
58. SAPOSNIK G, Hachinski V
    The pathway towards an effective reduction of stroke burden worldwide: teamwork.
    Lancet Neurol. 2019;18:622-623.
    PubMed    
    
    
    June 2019
59. TOYODA K, Uchiyama S, Yamaguchi T, Easton JD, et al
    Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2019;18:539-548.
    PubMed     Abstract available
    
    
    
60. HILL MD, Benavente OR
    The uncertain role for phosphodiesterase inhibitors in stroke prevention.
    Lancet Neurol. 2019;18:515-517.
    PubMed    
    
    
    
61. STINEAR CM
    Dopamine for motor recovery after stroke: where to from here?
    Lancet Neurol. 2019;18:514-515.
    PubMed    
    
    
    
62. FORD GA, Bhakta BB, Cozens A, Hartley S, et al
    Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2019;18:530-538.
    PubMed     Abstract available
    
    
    
63. THE LANCET NEUROLOGY
    Adding stroke to the political agenda in Europe.
    Lancet Neurol. 2019;18:513.
    PubMed    
    
    
    May 2019
64. WILSON D, Ambler G, Lee KJ, Lim JS, et al
    Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30197.
    PubMed     Abstract available
    
    
    
65. TSIVGOULIS G, Katsanos AH
    Can cerebral microbleeds predict stroke recurrence?
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30194.
    PubMed    
    
    
    
66. AL-SHAHI SALMAN R, Minks DP, Mitra D, Rodrigues MA, et al
    Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30184.
    PubMed     Abstract available
    
    
    
67. CHRISTENSEN H
    Antiplatelets after intracerebral haemorrhage: treat the patient, not the brain imaging.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30189.
    PubMed    
    
    
    April 2019
68. OURIQUES MARTINS SC, Sacks C, Hacke W, Brainin M, et al
    Priorities to reduce the burden of stroke in Latin American countries.
    Lancet Neurol. 2019 Apr 24. pii: S1474-4422(19)30068.
    PubMed     Abstract available
    
    
    
69. DICHGANS M, Pulit SL, Rosand J
    Stroke genetics: discovery, biology, and clinical applications.
    Lancet Neurol. 2019 Apr 8. pii: S1474-4422(19)30043.
    PubMed     Abstract available
    
    
    
70. SABA L, Saam T, Jager HR, Yuan C, et al
    Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications.
    Lancet Neurol. 2019 Apr 3. pii: S1474-4422(19)30035.
    PubMed     Abstract available
    
    
    
71. ALEXANDROV AV, Kohrmann M, Soinne L, Tsivgoulis G, et al
    Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
    Lancet Neurol. 2019;18:338-347.
    PubMed     Abstract available
    
    
    
72. GAUBERTI M
    Reperfusion in acute ischaemic stroke by sonothrombolysis.
    Lancet Neurol. 2019;18:320-321.
    PubMed    
    
    
    
73. BRAININ M
    Stroke epidemiology in China: which are the next steps?
    Lancet Neurol. 2019;18:325-326.
    PubMed    
    
    
    
74. WU S, Wu B, Liu M, Chen Z, et al
    Stroke in China: advances and challenges in epidemiology, prevention, and management.
    Lancet Neurol. 2019;18:394-405.
    PubMed     Abstract available
    
    
    March 2019
75. 
    Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30034.
    PubMed     Abstract available
    
    
    
76. GORELICK PB
    The global burden of stroke: persistent and disabling.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30030.
    PubMed    
    
    
    
77. OGAWA A, Toyoda K, Kitagawa K, Kitazono T, et al
    Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
    Lancet Neurol. 2019;18:238-247.
    PubMed     Abstract available
    
    
    
78. MELIS M, Ricci S, Toni D
    Optimal stroke prevention in patients with PFO.
    Lancet Neurol. 2019;18:231.
    PubMed    
    
    
    
79. DICHGANS M
    Dementia risk after transient ischaemic attack and stroke.
    Lancet Neurol. 2019;18:223-225.
    PubMed    
    
    
    
80. HANKEY GJ
    Prasugrel or clopidogrel for long-term secondary stroke prevention?
    Lancet Neurol. 2019;18:222-223.
    PubMed    
    
    
    
81. PENDLEBURY ST, Rothwell PM
    Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
    Lancet Neurol. 2019;18:248-258.
    PubMed     Abstract available
    
    
    February 2019
82. BROTT TG, Calvet D, Howard G, Gregson J, et al
    Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data.
    Lancet Neurol. 2019 Feb 6. pii: S1474-4422(19)30028.
    PubMed     Abstract available
    
    
    January 2019
83. WARDLAW JM, Bath PM
    Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets.
    Lancet Neurol. 2019;18:2-3.
    PubMed    
    
    
    December 2018
84. THIEBAUT AM, Gauberti M, Ali C, Martinez De Lizarrondo S, et al
    The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
    Lancet Neurol. 2018;17:1121-1132.
    PubMed     Abstract available
    
    
    
85. SCHEITZ JF, Nolte CH, Doehner W, Hachinski V, et al
    Stroke-heart syndrome: clinical presentation and underlying mechanisms.
    Lancet Neurol. 2018;17:1109-1120.
    PubMed     Abstract available
    
    
    November 2018
86. SEIFFGE DJ, Werring DJ, Paciaroni M, Dawson J, et al
    Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
    Lancet Neurol. 2018 Nov 8. pii: S1474-4422(18)30356.
    PubMed     Abstract available
    
    
    
87. CAMPBELL BCV, Majoie CBLM, Albers GW, Menon BK, et al
    Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30314.
    PubMed     Abstract available
    
    
    
88. WARACH S
    Patients with large brain infarcts might also benefit from thrombectomy.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30357.
    PubMed    
    
    
    October 2018
89. MEIER B
    Optimal stroke prevention in patients with patent foramen ovale.
    Lancet Neurol. 2018 Oct 16. pii: S1474-4422(18)30369.
    PubMed    
    
    
    
90. ROMAN LS, Menon BK, Blasco J, Hernandez-Perez M, et al
    Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018;17:895-904.
    PubMed     Abstract available
    
    
    
91. BROWN MM, Bonati LH
    The fate of severe restenosis after carotid interventions - Authors' reply.
    Lancet Neurol. 2018;17:843-844.
    PubMed    
    
    
    
92. ALBERS GW
    Endovascular thrombectomy in patients with large infarctions: reasons for restraint.
    Lancet Neurol. 2018;17:836-837.
    PubMed    
    
    
    September 2018
93. KASNER SE, Swaminathan B, Lavados P, Sharma M, et al
    Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Lancet Neurol. 2018 Sep 28. pii: S1474-4422(18)30319.
    PubMed     Abstract available
    
    
    
94. EKKER MS, Boot EM, Singhal AB, Tan KS, et al
    Epidemiology, aetiology, and management of ischaemic stroke in young adults.
    Lancet Neurol. 2018;17:790-801.
    PubMed     Abstract available
    
    
    
95. LIU T, Ding Y, Wen A
    Traditional Chinese medicine for ischaemic stroke.
    Lancet Neurol. 2018;17:745.
    PubMed    
    
    
    August 2018
96. DENNIS M
    Pharyngeal stimulation after stroke: more evidence is needed.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30312.
    PubMed    
    
    
    
97. DZIEWAS R, Stellato R, van der Tweel I, Walther E, et al
    Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30255.
    PubMed     Abstract available
    
    
    
98. AL-SHAHI SALMAN R, Frantzias J, Lee RJ, Lyden PD, et al
    Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.
    Lancet Neurol. 2018 Aug 14. pii: S1474-4422(18)30253.
    PubMed     Abstract available
    
    
    
99. WOO D, Anderson CD, Maguire J, Fornage M, et al
    Top research priorities for stroke genetics.
    Lancet Neurol. 2018;17:663-665.
    PubMed    
    
    
    July 2018
100. BUSHNELL C, Howard VJ, Lisabeth L, Caso V, et al
     Sex differences in the evaluation and treatment of acute ischaemic stroke.
     Lancet Neurol. 2018;17:641-650.
     PubMed     Abstract available
     
     
     
101. CHATURVEDI S
     Is surveillance for restenosis justified after carotid revascularisation?
     Lancet Neurol. 2018;17:570-571.
     PubMed    
     
     
     June 2018
102. MORGAN J
     A new life after stroke.
     Lancet Neurol. 2018 Jun 25. pii: S1474-4422(18)30249.
     PubMed    
     
     
     
103. MAZZUCCO S, Li L, Binney L, Rothwell PM, et al
     Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
     Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30167.
     PubMed     Abstract available
     
     
     
104. QUADRI M, Mandemakers W, Grochowska MM, Masius R, et al
     LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
     Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30179.
     PubMed     Abstract available
     
     
     
105. THALER D
     Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack.
     Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30198.
     PubMed    
     
     
     
106. WILSON D, Ambler G, Shakeshaft C, Brown MM, et al
     Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
     Lancet Neurol. 2018;17:539-547.
     PubMed     Abstract available
     
     
     
107. KIM BJ, Lee EJ, Kwon SU, Park JH, et al
     Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
     Lancet Neurol. 2018;17:509-518.
     PubMed     Abstract available
     
     
     
108. CORDONNIER C
     Balancing risks versus benefits of anticoagulants in stroke prevention.
     Lancet Neurol. 2018;17:487-488.
     PubMed    
     
     
     
109. AL-SHAHI SALMAN R
     A new era for comorbid cerebral ischaemia and haemorrhage.
     Lancet Neurol. 2018;17:482-483.
     PubMed    
     
     
     
110. THE LANCET NEUROLOGY
     Strong alliances to improve stroke care.
     Lancet Neurol. 2018;17:481.
     PubMed    
     
     
     May 2018
111. BONATI LH, Gregson J, Dobson J, McCabe DJH, et al
     Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial.
     Lancet Neurol. 2018 May 31. pii: S1474-4422(18)30195.
     PubMed     Abstract available
     
     
     
112. SCHWAMM LH
     Disruptive innovation in acute stroke systems of care.
     Lancet Neurol. 2018 May 25. pii: S1474-4422(18)30197.
     PubMed    
     
     
     April 2018
113. ROTHWELL PM
     Clinical innovation in stroke: getting the simple things right.
     Lancet Neurol. 2018 Apr 10. pii: S1474-4422(18)30113.
     PubMed    
     
     
     
114. 
     Yogeshwar Kalkonde.
     Lancet Neurol. 2018;17:305.
     PubMed    
     
     
     
115. CHARLIER P, Appenzeller O, Deo S, Perciaccante A, et al
     Hemiplegic migraine and stroke in Mary Shelley.
     Lancet Neurol. 2018;17:305.
     PubMed    
     
     
     February 2018
116. GALOVIC M, Dohler N, Keezer MR, Duncan JS, et al
     The SeLECT score is useful to predict post-stroke epilepsy.
     Lancet Neurol. 2018 Feb 15. pii: S1474-4422(18)30075.
     PubMed    
     
     
     
117. GALOVIC M, Dohler N, Erdelyi-Canavese B, Felbecker A, et al
     Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study.
     Lancet Neurol. 2018;17:143-152.
     PubMed     Abstract available
     
     
     
118. FINSTERER J
     The SeLECT score is inappropriate to predict post-stroke epilepsy.
     Lancet Neurol. 2018;17:106-107.
     PubMed    
     
     
     January 2018
119. RODRIGUES MA, Samarasekera N, Lerpiniere C, Humphreys C, et al
     The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.
     Lancet Neurol. 2018 Jan 10. pii: S1474-4422(18)30006.
     PubMed     Abstract available
     
     
     
120. CAMPBELL BCV, van Zwam WH, Goyal M, Menon BK, et al
     Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.
     Lancet Neurol. 2018;17:47-53.
     PubMed     Abstract available
     
     
     
121. DINSMORE J
     HERMES: a helpful messenger in the anaesthesia for thrombectomy debate?
     Lancet Neurol. 2018;17:21-23.
     PubMed    
     
     
     November 2017
122. CORLEY J
     Telestroke: India's solution to a public health-care crisis.
     Lancet Neurol. 2017 Nov 29. pii: S1474-4422(17)30423.
     PubMed    
     
     
     
123. BURTON A
     Trying to change the stroke landscape in Nigeria.
     Lancet Neurol. 2017;16:869-870.
     PubMed    
     
     
     October 2017
124. STINEAR CM
     Prediction of motor recovery after stroke: advances in biomarkers.
     Lancet Neurol. 2017;16:826-836.
     PubMed     Abstract available
     
     
     
125. WILSON L, Stewart W, Dams-O'Connor K, Diaz-Arrastia R, et al
     The chronic and evolving neurological consequences of traumatic brain injury.
     Lancet Neurol. 2017;16:813-825.
     PubMed     Abstract available
     
     
     
126. PLOUGHMAN M
     A new era of multiple sclerosis rehabilitation: lessons from stroke.
     Lancet Neurol. 2017;16:768-769.
     PubMed    
     
     
     September 2017
127. FINSTERER J
     Low risk of ischaemic stroke in hyperhomocysteinaemia.
     Lancet Neurol. 2017;16:682-683.
     PubMed    
     
     
     
128. SPENCE JD, Yi Q, Hankey GJ
     B vitamins in stroke prevention: time to reconsider.
     Lancet Neurol. 2017;16:750-760.
     PubMed     Abstract available
     
     
     
129. VAN VELUW SJ, Shih AY, Smith EE, Chen C, et al
     Detection, risk factors, and functional consequences of cerebral microinfarcts.
     Lancet Neurol. 2017;16:730-740.
     PubMed     Abstract available
     
     
     August 2017
130. ANDERSON CS
     NOR-TEST-ing tenecteplase in acute ischaemic stroke.
     Lancet Neurol. 2017 Aug 8. pii: S1474-4422(17)30277.
     PubMed    
     
     
     
131. LOGALLO N, Novotny V, Assmus J, Kvistad CE, et al
     Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
     Lancet Neurol. 2017 Aug 2. pii: S1474-4422(17)30253.
     PubMed     Abstract available
     
     
     
132. MAEGELE M, Schochl H, Menovsky T, Marechal H, et al
     Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management.
     Lancet Neurol. 2017;16:630-647.
     PubMed     Abstract available
     
     
     
133. SIHVONEN AJ, Sarkamo T, Leo V, Tervaniemi M, et al
     Music-based interventions in neurological rehabilitation.
     Lancet Neurol. 2017;16:648-660.
     PubMed     Abstract available
     
     
     July 2017
134. WACHTER R, Groschel K
     Atrial fibrillation in high-risk patients with ischaemic stroke - Authors' reply.
     Lancet Neurol. 2017;16:498.
     PubMed    
     
     
     
135. KNECHT S, Petsch S, Studer B
     Atrial fibrillation in high-risk patients with ischaemic stroke.
     Lancet Neurol. 2017;16:498.
     PubMed    
     
     
     May 2017
136. BERGE E, Salman RA, van der Worp HB, Stapf C, et al
     Increasing value and reducing waste in stroke research.
     Lancet Neurol. 2017;16:399-408.
     PubMed     Abstract available
     
     
     March 2017
137. HESS DC, Wechsler LR, Clark WM, Savitz SI, et al
     Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
     Lancet Neurol. 2017 Mar 17. pii: S1474-4422(17)30046.
     PubMed     Abstract available
     
     
     
138. DAVALOS A, Cobo E, Molina CA, Chamorro A, et al
     Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
     Lancet Neurol. 2017 Mar 16. pii: S1474-4422(17)30047.
     PubMed     Abstract available
     
     
     
139. FASSBENDER K, Grotta JC, Walter S, Grunwald IQ, et al
     Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.
     Lancet Neurol. 2017;16:227-237.
     PubMed     Abstract available
     
     
     
140. ELKINS J, Veltkamp R, Montaner J, Johnston SC, et al
     Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
     Lancet Neurol. 2017;16:217-226.
     PubMed     Abstract available
     
     
     
141. TATLISUMAK T
     Can natalizumab be beneficial in acute ischaemic stroke?
     Lancet Neurol. 2017;16:176-177.
     PubMed    
     
     
     February 2017
142. AMARENCO P, Albers GW, Denison H, Easton JD, et al
     Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
     Lancet Neurol. 2017 Feb 23. pii: S1474-4422(17)30038.
     PubMed     Abstract available
     
     
     
143. WACHTER R, Groschel K, Gelbrich G, Hamann GF, et al
     Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
     Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002.
     PubMed     Abstract available
     
     
     
144. BRACARD S, Ducrocq X, Guillemin F, Moulin T, et al
     Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke - Authors' reply.
     Lancet Neurol. 2017;16:104.
     PubMed    
     
     
     
145. BADHIWALA JH, Nassiri F, Kulkarni AV, Spears J, et al
     Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
     Lancet Neurol. 2017;16:103.
     PubMed    
     
     
     
146. MORELLI N, Rota E, Michieletti E, Guidetti D, et al
     Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
     Lancet Neurol. 2017;16:103-104.
     PubMed    
     
     
     November 2016
147. KELLY PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, et al
     Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
     Lancet Neurol. 2016;15:1238-1247.
     PubMed     Abstract available
     
     
     
148. HANLEY DF, Thompson RE, Muschelli J, Rosenblum M, et al
     Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
     Lancet Neurol. 2016;15:1228-1237.
     PubMed     Abstract available
     
     
     
149. KIM AS
     Stroke risk prediction after transient ischaemic attack.
     Lancet Neurol. 2016;15:1199-1200.
     PubMed    
     
     
     October 2016
150. TANG M, Ryman DC, McDade E, Jasielec MS, et al
     Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
     Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
     PubMed     Abstract available
     
     
     August 2016
151. BERKHEMER OA, Dippel DW
     Intra-arterial therapy for acute ischaemic stroke.
     Lancet Neurol. 2016 Aug 23. pii: S1474-4422(16)30197.
     PubMed    
     
     
     
152. THE LANCET NEUROLOGY
     The shared burden of stroke and dementia.
     Lancet Neurol. 2016;15:891.
     PubMed    
     
     
     July 2016
153. SEITZ RJ
     The pros and cons of intravenous thrombolysis in stroke.
     Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30159.
     PubMed    
     
     
     
154. RUDD AG
     Can emergency stroke care be delivered in an ambulance?
     Lancet Neurol. 2016 Jul 15. pii: S1474-4422(16)30162.
     PubMed    
     
     
     
155. FRASER JF
     Standardisation of research strategies in acute ischaemic stroke.
     Lancet Neurol. 2016;15:784-5.
     PubMed    
     
     
     
156. AL-SHAHI SALMAN R, McGoohan K, Rodrigues M, Dichgans M, et al
     Dementia after stroke due to intracerebral haemorrhage.
     Lancet Neurol. 2016;15:779-80.
     PubMed    
     
     
     June 2016
157. SILVER B
     Virtual reality versus reality in post-stroke rehabilitation.
     Lancet Neurol. 2016 Jun 27. pii: S1474-4422(16)30126.
     PubMed    
     
     
     
158. HACHINSKI V, Azarpazhooh MR
     Stroke is a burdensome but preventable brain disorder.
     Lancet Neurol. 2016 Jun 9. pii: S1474-4422(16)30120.
     PubMed    
     
     
     
159. KIECHL S, Willeit J
     Alteplase in acute ischaemic stroke: no time to slow down.
     Lancet Neurol. 2016 Jun 8. pii: S1474-4422(16)30095.
     PubMed    
     
     
     
160. HACHINSKI V, Sposato LA, Kapral M
     Preventing both stroke and dementia.
     Lancet Neurol. 2016;15:659.
     PubMed    
     
     
     
161. BRAYNE C, Wu YT
     Preventing both stroke and dementia - Authors' reply.
     Lancet Neurol. 2016;15:659.
     PubMed    
     
     
     
162. VON KUMMER R
     Early CT Score to establish stroke treatment.
     Lancet Neurol. 2016;15:651-3.
     PubMed    
     
     
     
163. CORALLI A, Perciaccante A
     Leonardo's recurrent stroke?
     Lancet Neurol. 2016;15:667.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: